Results 81 to 90 of about 6,519,345 (216)

Advances in therapeutic peptides targeting G protein-coupled receptors

Nature reviews. Drug discovery, 2020
A. Davenport, Conor C. G. Scully, C. de Graaf, Alastair J. H. Brown, J. Maguire   +4 more
semanticscholar   +1 more source

Further Insights Into Anticholinergic Action Informed by Japanese Anticholinergic Risk Scale. [PDF]

Geriatr Gerontol Int
Mogi M, Liu S, Suzuki Y, Shibata Y, Yamada S.   +4 more
europepmc   +1 more source

Ligand-modified liposomes as drug delivery systems for the active targeting of pancreatic cancer. [PDF]

Int J Pharm X
Jang Y, Jang J, Son J, Lee HY, Choi J.
europepmc   +1 more source

A Hypersexuality Subset Behavior Induced by Aripiprazole Overdose in an Antipsychotic Naïve Patient: A Case Report and Review of the Literature. [PDF]

Clin Pract
Serfilippi T, Piccirillo S, Preziuso A, Terenzi V, Romagnoli F, Tarini M, Lariccia V, Secondo A, Magi S.   +8 more
europepmc   +1 more source

SOME QUANTITATIVE USES OF DRUG ANTAGONISTS

British Journal of Pharmacology and Chemotherapy, 1997
O. Arunlakshana, Schild Ho
semanticscholar   +1 more source

Neuronal Inhibition in Epilepsy: Native Human GABA-A Receptors and Pharmacological Chaperones Restoring Expression of Disease Associated Variants. [PDF]

Epilepsy Curr
Durisic N, Borges K.
europepmc   +1 more source

REV-ERB and ROR nuclear receptors as drug targets

Nature reviews. Drug discovery, 2014
D. Kojetin, T. Burris
semanticscholar   +1 more source

Nanobody-drug conjugates for targeting specific GPCR pairs. [PDF]

PLoS Biol
Huang X, Roth BL.
europepmc   +1 more source

Role of Glutamate and NMDA Receptors in Alzheimer’s Disease

Journal of Alzheimer's Disease, 2016
Rui Wang, P. Reddy
semanticscholar   +1 more source

The metabolic dysfunction-associated steatohepatitis (MASH) drug resmetirom exhibits broad nuclear receptor activity with minimal functional impact. [PDF]

Sci Rep
Kärcher A, Isigkeit L, Bandomir NC, Schubert-Zsilavecz M, Heitel P.   +4 more
europepmc   +1 more source